biotech · Chronic Inducible Urticaria · Chronic Spontaneous Urticaria · JSPR
Jasper Therapeutics
Jasper Therapeutics patent portfolio — 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Redwood City, CA, US HQ
44 Employees
Public company Type
JSPR · NYSE Ticker
Company details
- Status
- Public
- HQ
- Redwood City, CA, US
- Employees
- 44
- Programs
- 13
- Drugs
- 13
- Patents
- 1
Jasper Therapeutics patents
1 pharmaceutical patents indexed for Jasper Therapeutics. 0 expire within 24 months.
Jasper Therapeutics has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does Jasper Therapeutics have?
1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Jasper Therapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.